Ethical considerations and rationale of the MAKI trial: A multicenter double-blind randomized placebo-controlled trial into the preventive effect of palivizumab on recurrent wheezing associated with respiratory syncytial virus infection in children with a gestational age of 33-35weeks

Contemporary Clinical Trials

Volumn 33, Issue 6, 2012, Pages 1287-1292

  Blanken, Maarten ^a   Rovers, Maroeska ^b   Sanders, Elisabeth ^a   Bont, Louis ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Late preterm infants; Post bronchiolitis wheezing; Respiratory syncytial virus

Indexed keywords

PALIVIZUMAB; PLACEBO;

ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG SAFETY; GENERAL PRACTITIONER; GESTATIONAL AGE; HUMAN; IMMUNOPROPHYLAXIS; INFANT; INJECTION SITE ERYTHEMA; MULTICENTER STUDY; NOSE SMEAR; POST BRONCHIOLITIS WHEEZING; PREMATURITY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RESEARCH ETHICS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; STUDY DESIGN; TREATMENT OUTCOME; WHEEZING;

ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIVIRAL AGENTS; DOUBLE-BLIND METHOD; ETHICS, RESEARCH; FEMALE; GESTATIONAL AGE; HUMANS; INFANT; INFANT, NEWBORN; MALE; RECURRENCE; RESPIRATORY SOUNDS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;

EID: 84867198166     PISSN: 15517144     EISSN: 15592030     Source Type: Journal    
DOI: 10.1016/j.cct.2012.07.010     Document Type: Article

References (25)

1. Hall C.B., Weinberg G.A., Iwane M.K., Blumkin A.K., Edwards K.M., Staat M.A., et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med Feb 5 2009, 360(6):588-598.
2. Smyth R.L., Openshaw P.J. Bronchiolitis. Lancet Jul 22 2006, 368(9532):312-322.
3. Ermers M.J., Rovers M.M., van Woensel J.B., Kimpen J.L., Bont L.J. The effect of high dose inhaled corticosteroids on wheeze in infants after respiratory syncytial virus infection: randomised double blind placebo controlled trial. BMJ 2009, 338:b897.
4. Bont L., Kimpen J.L. Immunological mechanisms of severe respiratory syncytial virus bronchiolitis. Intensive Care Med May 2002, 28(5):616-621.
5. Tissing W.J.E., Van Steensel-Moll H.A., Offringa M. Risk factors for mechanical ventilation in respiratory syncytial virus infection. Eur J Pediatr 1993, 152:125-127.
6. Bont L., Aalderen vWMC, Kimpen J.L.L. Long-term consequences of respiratory syncytial virus (RSV) bronchiolitis. Paediatr Respir Rev 2000, 1(3):221-227.
7. Bont L., Steijn M., van Aalderen W.M., Kimpen J.L. Impact of wheezing after respiratory syncytial virus infection on health-related quality of life. PIDJ May 2004, 23(5):414-417.
8. Simon A., Ammann R.A., Wilkesmann A., Eis-Hubinger A.M., Schildgen O., Weimann E., et al. Respiratory syncytial virus infection in 406 hospitalized premature infants: results from a prospective German multicentre database. Eur J Pediatr Dec 2007, 166(12):1273-1283.
9. Sampalis J.S. Morbidity and mortality after RSV-associated hospitalizations among premature Canadian infants. J Pediatr Nov 2003, 143(Suppl. 5):S150-S156.
10. Prais D., Schonfeld T., Amir J. Admission to the intensive care unit for respiratory syncytial virus bronchiolitis: a national survey before palivizumab use. Pediatrics Sep 2003, 112(3 Pt 1):548-552.
11. Stensballe L.G., Devasundaram J.K., Simoes E.A. Respiratory syncytial virus epidemics: the ups and downs of a seasonal virus. PIDJ Feb 2003, 22(Suppl. 2):S21-S32.
12. Boyce T.G., Mellen B.G., Mitchel E.F., Wright P.F., Griffin M.R. Rates of hospitalization for respiratory syncytial virus infection among children in medicaid. J Pediatr Dec 2000, 137(6):865-870.
13. Weisman L.E. Populations at risk for developing respiratory syncytial virus and risk factors for respiratory syncytial virus severity: infants with predisposing conditions. PIDJ Feb 2003, 22(Suppl. 2):S33-S37.
14. Welliver R.C. Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection. J Pediatr Nov 2003, 143(Suppl. 5):S112-S117.
15. Bloemers B.L., van Furth A.M., Weijerman M.E., Gemke R.J., Broers C.J., van den E.K., et al. Down syndrome: a novel risk factor for respiratory syncytial virus bronchiolitis--a prospective birth-cohort study. Pediatrics Oct 2007, 120(4):e1076-e1081.
16. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group. Pediatrics Sep 1998, 102(3 Pt 1):531-537.
17. Carbonell-Estrany X., Simoes E.A., Dagan R., Hall C.B., Harris B., Hultquist M., et al. Motavizumab for prophylaxis of respiratory syncytial virus in high-risk children: a noninferiority trial. Pediatrics Jan 2010, 125(1):e35-e51.
18. Feltes T.F., Cabalka A.K., Meissner H.C., Piazza F.M., Carlin D.A., Top F.H., et al. Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease. J Pediatr Oct 2003, 143(4):532-540.
19. Bont L., Steijn M., van Aalderen W.M., Brus F., Th Draaisma J.M., Van Diemen-Steenvoorde R.A., et al. Seasonality of long term wheezing following respiratory syncytial virus lower respiratory tract infection. Thorax Jun 2004, 59(6):512-516.
20. Bont L., van Aalderen W.M., Versteegh J., Brus F., Draaisma J.T., Pekelharing-Berghuis M., et al. Airflow limitation during respiratory syncytial virus lower respiratory tract infection predicts recurrent wheezing. PIDJ Mar 2001, 20(3):277-282.
21. Simoes E.A., Groothuis J.R., Carbonell-Estrany X., Rieger C.H., Mitchell I., Fredrick L.M., et al. Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing. J Pediatr Jul 2007, 151(1):34-42. [42].
22. Broughton S., Bhat R., Roberts A., Zuckerman M., Rafferty G., Greenough A. Diminished lung function, RSV infection, and respiratory morbidity in prematurely born infants. Arch Dis Child Jan 2006, 91(1):26-30.
23. Lakwijk N., Van Strien R.T., Doekes G., Brunekreef B., Gerritsen J. Validation of a screening questionnaire for atopy with serum IgE tests in a population of pregnant Dutch women. Clin Exp Allergy Apr 1998, 28(4):454-458.
24. Bont L., Heijnen C.J., Kavelaars A., van Aalderen W.M., Brus F., Draaisma J.T., et al. Monocyte IL-10 production during respiratory syncytial virus bronchiolitis is associated with recurrent wheezing in a one-year follow-up study. Am J Respir Crit Care Med May 2000, 161(5):1518-1523.
25. TAPQOL - TNO-AZL Questionnaire for Preschool Children's Health-Related Quality of Life 2012, Ref Type: Data File.